Mini Review
Nanoparticulate Carriers of Anticancer Drugs and Therapeutics
Ignác Capek, Institute of Measurement Sciences SAS, Bratislava, Slovakia.
Received Date: March 28, 2019; Published Date: April 08, 2019
Abstract
Nanoscale drug delivery platforms have been developed over the past four decades that have shown promising clinical results in several types of cancer and inflammatory disorders. Nanoparticles have special characteristics of high surface to volume ratio, size controllability, and can be easily functionalized during synthesis [1]. Biodegradable polymer nanoparticles have been used as carriers for drugs, peptides, proteins, vaccines, and nucleotides [2]. Nanoparticles (NPs) can protect drug moieties from degradation and provide sustained drug release.
-
Ignác Capek. Nanoparticulate Carriers of Anticancer Drugs and Therapeutics. Adv Can Res & Clinical Imag. 1(3): 2019. ACRCI. MS.ID.000515.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.